ゲノム編集・ゲノム工学の世界市場レポート 2025年

ゲノム編集・ゲノム工学の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR19.5％で208億1,000万米ドルに成長します。予測期間の成長は、プライム編集の出現、倫理的・規制的枠組みの重視、創薬における採用の増加、遺伝性疾患の治療可能性、遺伝子機能研究のためのカスタマイズ、エピゲノム編集への関心の高まりなどに起因すると考えられます。予測期間の主な動向には、CRISPR技術の進歩、治療薬の応用拡大、新しいゲノム編集ツールの登場、投資と提携、デリバリーシステムの強化、ゲノム編集設計における人工知能（AI）の統合などが含まれます。

がんおよびその他の遺伝性疾患の有病率の増加は、ゲノム編集・ゲノム工学市場の今後の成長を促進すると予想されます。がんは、体内の特定の細胞の制御不能な増殖を特徴とする病態であり、他の部位に転移する可能性があります。ゲノム編集は、がん治療における治療目的のために、免疫細胞や腫瘍溶解性ウイルスを迅速に改変する可能性を秘めています。例えば2022年2月、スイスに本部を置く国連の機関である世界保健機関（WHO）が発表した論文によると、死亡者数の約6人に1人に当たる約1,000万人ががんに起因しており、世界の死因の第1位となっています。さらに、米国を拠点とする国の公衆衛生機関である疾病対策予防センター（CDC）の2022年6月の報告書によると、2019年に米国で新たに診断された浸潤性がんの症例は175万2,735人で、そのうち女性は86万3,830人、男性は88万8,905人でした。全がんの罹患率は、一般人口10万人当たり439人でした。したがって、がんやその他の遺伝性疾患の有病率の上昇が、ゲノム編集・ゲノム工学市場の成長を促進しています。

予想される研究活動の増加は、ゲノム編集・ゲノム工学市場の今後の成長を促進します。研究活動には、特定の分野における新たな知識や洞察の収集、分析、解釈、生成を目的とした、個人、チーム、または機関による体系的かつ組織的な取り組みが含まれます。ゲノム編集・ゲノム工学は、科学的探求を大きく再形成し、増加する研究状況の極めて重要な推進力として台頭してきました。これらの画期的なツールによって、研究者は生物の複雑な遺伝子構造を正確に改変し、理解することができるようになり、比類のない精度と柔軟性がもたらされるようになりました。例えば、2024年2月、英国の国家統計局は、2022年に英国企業が研究開発（R&D）に499億ポンド（652億9,000万米ドル）を投資し、2021年と比較して30億ポンド（39億3,000万米ドル）、6.4％の増加を記録したと報告しました。このように、研究活動の活発化がゲノム編集・ゲノム工学市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のゲノム編集・ゲノム工学市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のゲノム編集・ゲノム工学市場：成長率分析
• 世界のゲノム編集・ゲノム工学市場の実績：規模と成長、2019～2024年
• 世界のゲノム編集・ゲノム工学市場の予測：規模と成長、2024～2029年、2034年
• 世界のゲノム編集・ゲノム工学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のゲノム編集・ゲノム工学市場：製品とサービス別、実績と予測、2019～2024年、2024～2029年、2034年
• 試薬および消耗品
• ソフトウェアとシステム
• サービス
• 世界のゲノム編集・ゲノム工学市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• CRISPR
• TALEN
• ZFN
• アンチセンス
• その他
• 世界のゲノム編集・ゲノム工学市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 細胞株光学
• 遺伝子工学
• 診断用途
• 創薬と開発
• その他
• 世界のゲノム編集・ゲノム工学市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• バイオテクノロジー企業
• 製薬会社
• 学術機関および政府研究機関
• 世界のゲノム編集・ゲノム工学市場：試薬および消耗品のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• CRISPRまたはCas9キット
• TALENsキット
• ジンクフィンガーヌクレアーゼ（ZFN）
• ドナーDNAテンプレート
• ヌクレオチド試薬
• 世界のゲノム編集・ゲノム工学市場：ソフトウェアとシステムのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ゲノム編集設計ソフトウェア
• 分析および視覚化ツール
• ワークフロー管理システム
• 世界のゲノム編集・ゲノム工学市場：サービスのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 遺伝子合成およびクローニングサービス
• カスタムゲノム編集サービス
• ゲノム編集プロジェクトに関するコンサルティングサービス

第7章 地域別・国別分析

• 世界のゲノム編集・ゲノム工学市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のゲノム編集・ゲノム工学市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ゲノム編集・ゲノム工学市場：競合情勢
• ゲノム編集・ゲノム工学市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • Genscript Biotech Corp Overview, Products and Services, Strategy and Financial Analysis
  • Sangamo Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Editas Medicine Inc.
• CRISPR Therapeutics AG
• Agilent Technologies Inc.
• Intellia Therapeutics
• bluebird bio Inc.
• Transposagen Biopharmaceuticals Inc.
• Tecan Trading AG
• Precision BioSciences
• PerkinElmer Inc.
• Cellectis S.A
• Applied StemCell Inc.
• Bio-Rad Laboratories Inc.
• Bio-Techne
• Creative Biogene
• Cyagen Biosciences

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ゲノム編集・ゲノム工学市場2029年：新たな機会を提供する国
• ゲノム編集・ゲノム工学市場2029年：新たな機会を提供するセグメント
• ゲノム編集・ゲノム工学市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Genome editing is a technique that allows scientists to modify the DNA of various organisms, including plants, bacteria, and animals. This technology enables the alteration of DNA, influencing physical characteristics such as eye color and the susceptibility to diseases. Genome editing is extensively used in research labs with animal models and cells to gain insights into diseases.

The main products and services in genome editing and genome engineering encompass reagents and consumables, software and systems, and services. Reagents and consumables are utilized at specific locations in the genome of a target organism to induce breaks, repairs, or mismatches, leveraging endogenous mechanisms to bring about specific changes in the DNA sequence. Consumables are items used until depletion and then disposed of, while reagents are compounds or substances that facilitate a reaction. Various technologies, including Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nucleases (ZFN), antisense, and others, are employed in genome editing. These technologies find applications in cell line engineering, genetic engineering, diagnostic applications, drug discovery and development, and various other fields. The users of genome editing technologies include biotechnology companies, pharmaceutical companies, academic and government research institutes.

The genome editing or genome engineering market research report is one of a series of new reports from The Business Research Company that provides genome editing or genome engineering market statistics, including genome editing or genome engineering industry global market size, regional shares, competitors with a genome editing or genome engineering market share, detailed genome editing or genome engineering market segments, market trends and opportunities, and any further data you may need to thrive in the genome editing or genome engineering industry. This genome editing or genome engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genome editing/genome engineering market size has grown rapidly in recent years. It will grow from $8.62 billion in 2024 to $10.2 billion in 2025 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to increasing research in genetics and genomics, rise in genetic diseases, gene therapy advancements, investments in biotechnology and life sciences, potential for agricultural applications, application in model organisms.

The genome editing/genome engineering market size is expected to see rapid growth in the next few years. It will grow to $20.81 billion in 2029 at a compound annual growth rate (CAGR) of 19.5%. The growth in the forecast period can be attributed to emergence of prime editing, focus on ethical and regulatory frameworks, increasing adoption in drug discovery, therapeutic potential for genetic disorders, customization for gene function studies, growing interest in epigenome editing. Major trends in the forecast period include advancements in Crispr technology, growing applications in therapeutics, emergence of new genome editing tools, investments and partnerships, enhanced delivery systems, integration of artificial intelligence (ai) in genome editing design.

The increasing prevalence of cancer and other genetic disorders is anticipated to drive the growth of the genome editing and genome engineering market in the future. Cancer is a condition characterized by the uncontrolled growth of certain cells in the body, which can spread to other areas. Genome editing has the potential to rapidly engineer immune cells and oncolytic viruses for therapeutic purposes in cancer treatment. For instance, in February 2022, an article published by the World Health Organization (WHO), a Switzerland-based agency of the United Nations, reported that nearly 10 million deaths, or approximately one in six deaths, were attributed to cancer, making it the leading cause of death globally. Additionally, a June 2022 report from the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, indicated that 1,752,735 new cases of invasive cancer were diagnosed in the US in 2019, including 863,830 women and 888,905 men. The overall incidence rate for all cancers was 439 per 100,000 individuals in the general population. Therefore, the rising prevalence of cancer and other genetic disorders is propelling the growth of the genome editing and genome engineering market.

An anticipated rise in research activities is set to propel the growth of the genome editing and genome engineering market in the future. Research activities involve systematic and organized efforts by individuals, teams, or institutions aimed at gathering, analyzing, interpreting, and generating new knowledge or insights within a specific field. Genome editing and genome engineering have emerged as pivotal drivers of the increasing research landscape, significantly reshaping scientific exploration. These groundbreaking tools enable researchers to precisely modify and understand the complex genetic structures of organisms, providing unmatched accuracy and flexibility. For example, in February 2024, The Office for National Statistics, a UK-based agency, reported that in 2022, UK businesses invested £49.9 billion ($65.29 billion) in research and development (R&D), marking an increase of £3.0 billion ($3.93 billion) or 6.4% compared to 2021. Consequently, the rise in research activities is fueling the growth of the genome editing and genome engineering market.

The genome editing or genome engineering market is witnessing a key trend in technological advancements in gene editing. Major companies are focusing on developing innovative technology solutions to enhance their position in the market. For instance, researchers at Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra) have introduced a novel gene-editing method called Direct Parental CRISPR (DIPA-CRISPR). This technique offers a quick and effective means of editing genes in insects by injecting materials into developing eggs in female adults, bypassing the traditional method of microinjecting CRISPR material into insect embryos. The adoption of advanced gene-editing technologies is contributing to the efficiency and precision of genetic modifications.

Major companies operating in the genome editing or genome engineering market are engaging in strategic partnerships to fortify their positions. Strategic partnerships, such as the collaboration between Ionis Pharmaceuticals Inc. and Metagenomi, aim to expand and diversify technological capabilities. Ionis Pharmaceuticals Inc., a biotechnology company, partnered with Metagenomi, a genomic medicines company, to leverage their respective technologies and deliver transformative therapies focused on genetic targets. Such collaborations enable companies to pool resources, share expertise, and innovate collectively, fostering advancements in the genome editing or genome engineering field.

In September 2022, Lesaffre, a France-based microorganisms, healthcare and biotechnology company acquired Recombia Biosciences for an undisclosed amount. The acquisition aims to leverage Recombia Biosciences' genome-editing technologies and accelerate the development of yeasts for sustainable production of fermented ingredients. Recombia Biosciences is a US-based biotechnology company.

Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

North America was the largest region in the gene editing or genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing or genome engineering market report during the forecast period. The regions covered in the genome editing or genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genome editing or genome engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genome editing or genome engineering market includes revenues earned by entities through cell line engineering, animal genetic engineering, and plant genetic engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genome Editing/Genome Engineering Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genome editing/genome engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genome editing/genome engineering ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genome editing/genome engineering market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Reagents And Consumables; Software And systems; Services
• 2) By Technology: CRISPR; TALEN; ZFN; Antisense; Other Technologies
• 3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development; Other Applications
• 4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes
• Subsegments:
• 1) By Reagents And Consumables: CRISPR Or Cas9 Kits; TALENs Kits; Zinc Finger Nucleases (ZFNs); Donor DNA Templates; Nucleotide Reagents
• 2) By Software And Systems: Genome Editing Design Software; Analysis And Visualization Tools; Workflow Management Systems
• 3) By Services: Gene Synthesis And Cloning Services; Custom Genome Editing Services; Consulting Services For Genome Editing Projects
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck Group; Genscript Biotech Corp; Sangamo Therapeutics Inc.; Lonza Group AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genome Editing/Genome Engineering Market Characteristics

3. Genome Editing/Genome Engineering Market Trends And Strategies

4. Genome Editing/Genome Engineering Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Genome Editing/Genome Engineering Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genome Editing/Genome Engineering PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genome Editing/Genome Engineering Market Growth Rate Analysis
• 5.4. Global Genome Editing/Genome Engineering Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genome Editing/Genome Engineering Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genome Editing/Genome Engineering Total Addressable Market (TAM)

6. Genome Editing/Genome Engineering Market Segmentation

• 6.1. Global Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Consumables
• Software And systems
• Services
• 6.2. Global Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR
• TALEN
• ZFN
• Antisense
• Other Technologies
• 6.3. Global Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Line Engineering
• Genetic Engineering
• Diagnostic Applications
• Drug Discovery And Development
• Other Applications
• 6.4. Global Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology Companies
• Pharmaceutical Companies
• Academic And Government Research Institutes
• 6.5. Global Genome Editing/Genome Engineering Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR Or Cas9 Kits
• TALENs Kits
• Zinc Finger Nucleases (ZFNs)
• Donor DNA Templates
• Nucleotide Reagents
• 6.6. Global Genome Editing/Genome Engineering Market, Sub-Segmentation Of Software And Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genome Editing Design Software
• Analysis And Visualization Tools
• Workflow Management Systems
• 6.7. Global Genome Editing/Genome Engineering Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Synthesis And Cloning Services
• Custom Genome Editing Services
• Consulting Services For Genome Editing Projects

7. Genome Editing/Genome Engineering Market Regional And Country Analysis

• 7.1. Global Genome Editing/Genome Engineering Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genome Editing/Genome Engineering Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genome Editing/Genome Engineering Market

• 8.1. Asia-Pacific Genome Editing/Genome Engineering Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genome Editing/Genome Engineering Market

• 9.1. China Genome Editing/Genome Engineering Market Overview
• 9.2. China Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genome Editing/Genome Engineering Market

• 10.1. India Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genome Editing/Genome Engineering Market

• 11.1. Japan Genome Editing/Genome Engineering Market Overview
• 11.2. Japan Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genome Editing/Genome Engineering Market

• 12.1. Australia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genome Editing/Genome Engineering Market

• 13.1. Indonesia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genome Editing/Genome Engineering Market

• 14.1. South Korea Genome Editing/Genome Engineering Market Overview
• 14.2. South Korea Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genome Editing/Genome Engineering Market

• 15.1. Western Europe Genome Editing/Genome Engineering Market Overview
• 15.2. Western Europe Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genome Editing/Genome Engineering Market

• 16.1. UK Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genome Editing/Genome Engineering Market

• 17.1. Germany Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genome Editing/Genome Engineering Market

• 18.1. France Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genome Editing/Genome Engineering Market

• 19.1. Italy Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genome Editing/Genome Engineering Market

• 20.1. Spain Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genome Editing/Genome Engineering Market

• 21.1. Eastern Europe Genome Editing/Genome Engineering Market Overview
• 21.2. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genome Editing/Genome Engineering Market

• 22.1. Russia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genome Editing/Genome Engineering Market

• 23.1. North America Genome Editing/Genome Engineering Market Overview
• 23.2. North America Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genome Editing/Genome Engineering Market

• 24.1. USA Genome Editing/Genome Engineering Market Overview
• 24.2. USA Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genome Editing/Genome Engineering Market

• 25.1. Canada Genome Editing/Genome Engineering Market Overview
• 25.2. Canada Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genome Editing/Genome Engineering Market

• 26.1. South America Genome Editing/Genome Engineering Market Overview
• 26.2. South America Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genome Editing/Genome Engineering Market

• 27.1. Brazil Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genome Editing/Genome Engineering Market

• 28.1. Middle East Genome Editing/Genome Engineering Market Overview
• 28.2. Middle East Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genome Editing/Genome Engineering Market

• 29.1. Africa Genome Editing/Genome Engineering Market Overview
• 29.2. Africa Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genome Editing/Genome Engineering Market Competitive Landscape And Company Profiles

• 30.1. Genome Editing/Genome Engineering Market Competitive Landscape
• 30.2. Genome Editing/Genome Engineering Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Genscript Biotech Corp Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sangamo Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Genome Editing/Genome Engineering Market Other Major And Innovative Companies

• 31.1. Editas Medicine Inc.
• 31.2. CRISPR Therapeutics AG
• 31.3. Agilent Technologies Inc.
• 31.4. Intellia Therapeutics
• 31.5. bluebird bio Inc.
• 31.6. Transposagen Biopharmaceuticals Inc.
• 31.7. Tecan Trading AG
• 31.8. Precision BioSciences
• 31.9. PerkinElmer Inc.
• 31.10. Cellectis S.A
• 31.11. Applied StemCell Inc.
• 31.12. Bio-Rad Laboratories Inc.
• 31.13. Bio-Techne
• 31.14. Creative Biogene
• 31.15. Cyagen Biosciences

32. Global Genome Editing/Genome Engineering Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genome Editing/Genome Engineering Market

34. Recent Developments In The Genome Editing/Genome Engineering Market

35. Genome Editing/Genome Engineering Market High Potential Countries, Segments and Strategies

• 35.1 Genome Editing/Genome Engineering Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genome Editing/Genome Engineering Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genome Editing/Genome Engineering Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer